The drug, which is meant to treat Type 2 diabetes, was compared with Novo Nordisk’s oral semaglutide, and showed greater improvements in blood sugar levels, known as A1C, and greater weight loss.

Eli Lilly (LLY) stock is in focus as the company posts detailed data from a late-stage trial for its obesity pill ...

Vibe coding is the hot trend. You enter prompts into AI that tell it to produce a program for you. Voila, it generates the ...